Discriminatory Vaccine Policy Based on Falsified Paper
WASHINGTON, Nov. 17, 2012 /PRNewswire/ -- CoMeD -- As the Inspector General for Health and Human Services names vaccine researcher Poul Thorsen as one of its "Most Wanted" fugitives, the defense of mercury as 'safe in vaccines' seems to be crumbling.
In 2010, the Coalition for Mercury-free Drugs (CoMeD, Inc.) submitted an allegation to the Inspector General, that studies showing mercury-containing vaccines to be safe, are fraudulent. Now, a new "wanted" posted featuring Danish vaccine researcher Poul Thorsen, issued by the Inspector General (HHS-OIG), offers proof this allegation is credible.
It is estimated that Poul Thorsen embezzled at least one million dollars of grant money from the CDC, while he co-authored, "Thimerosal and the occurrence of autism …". CDC documents, obtained through FOIA, also show that Thorsen and his co-authors concealed the fact that autism declined in Denmark after Thimerosal was removed from the Danish vaccine program.
Today, the US Government and the World Health Organization defend the ongoing use of Thimerosal, the highly toxic mercury-based vaccine preservative, based on a handful of industry-sponsored statistical studies, including Thorsen's. The manufacturer's Material Safety Data Sheet for Thimerosal, however, lists mental retardation as a possible outcome from exposure in utero and in children.
Based on Thorsen's public conclusion, Dr. Jose Cordero, former US Assistant Surgeon General, declared that "(Thorsen's) Danish study…provide(s) one strong piece of evidence that Thimerosal is not causally linked to autism." Disturbingly, this study also helped the Institute of Medicine reach its 2004 declaration that mercury in vaccines is unrelated to the autism epidemic.
Globally, the proponents for Thimerosal-preserved vaccines are using this questionable research to justify providing mercury-preserved vaccines to developing countries. While children in developed, western, nations receive mercury-free vaccine formulations, children in developing countries receive many mercury-preserved ones.
At the fourth meeting of the United Nations Intergovernmental Negotiating Committee (INC4) to write a global treaty on mercury, Rev. Lisa K. Sykes, President of CoMeD, Inc., termed this double standard in vaccine safety a form of discrimination based on economics and nationality. It now seems this discrimination is also based upon falsified data and criminal conduct.
Despite this, the US National Institutes of Health and Centers for Disease Control and Prevention continue to collaborate with Poul Thorsen, using federal funds. Thorsen remains in Denmark, and no date for his extradition has been made public.
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Get content for your website
Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Contact PR Newswire
Send us an email at MarketingUK@prnewswire.co.uk or call us at +44 (0)20 7454 5382
Become a PR Newswire client
Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382